XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2

SEGMENT INFORMATION (Tables)

9 Months Ended

Jul. 31, 2021

Segment Reporting [Abstract]

Segment Profitability and Segment Assets

The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:

			Three Months Ended												Nine Months Ended
			July 31,												July 31,
			2021						2020						2021						2020
			(in millions)
Net Revenue:
Life Sciences and Applied Markets			$	680					$	557					$	2,076					$	1,721
Diagnostics and Genomics			346						241						955						753
Agilent CrossLab			560						463						1,628						1,382
Total net revenue			$	1,586					$	1,261					$	4,659					$	3,856
Segment Income From Operations:
Life Sciences and Applied Markets			$	170					$	126					$	523					$	382
Diagnostics and Genomics			78						41						202						132
Agilent CrossLab			164						132						447						373
Total segment income from operations			$	412					$	299					$	1,172					$	887

The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.  

			July 31, 2021						October 31, 2020
			(in millions)
Segment Assets:
Life Sciences and Applied Markets			$	3,116					$	3,143
Diagnostics and Genomics			3,278						2,515
Agilent CrossLab			1,456						1,375
Total segment assets			$	7,850					$	7,033

Reconciliation of segment results to total enterprise results

The following table reconciles segment income from operations to Agilent’s total enterprise income before taxes: 

			Three Months Ended												Nine Months Ended
			July 31,												July 31,
			2021						2020						2021						2020
			(in millions)
Total segment income from operations			$	412					$	299					$	1,172					$	887
Transformational initiatives			(12)						(13)						(32)						(41)
Amortization of intangible assets related to business combinations			(53)						(45)						(143)						(139)
Acquisition and integration costs			(10)						(9)						(32)						(33)
Asset impairment			—						—						(2)						(99)
Business exit and divestiture costs			—						—						(4)						—
Other(1)			(1)						(2)						(7)						(28)
Interest income			—						1						1						7
Interest expense			(21)						(19)						(60)						(59)
Other income (expense), net (2)			12						7						19						64
Income before taxes, as reported			$	327					$	219					$	912					$	559

(1) For the nine months ended July 31, 2020, the other category primarily includes the legal costs related to a claim we pursued against Twist Bioscience Corporation in addition to other miscellaneous adjustments.

(2) For the nine months ended July 31, 2020 other income (expense), net includes the settlement of the legal claim against Twist Bioscience Corporation.

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration